Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

Phase 1/2 Unknown 32 enrolled Medical University of Vienna

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study investigates the efficacy of landiolol versus placebo in patients with out-of-hospital cardiac arrest (OHCA) and refractory ventricular fibrillation (electrical storm).

Timeline

Start: 2021-03-03
Primary completion: 2023-12-31
Completion: 2023-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Landiolol	Small molecule	20 mg	—

Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest

Summary

Timeline

Drugs

Indications